Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 1
2021 2
2022 3
2023 2
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
O-SEMA-FAST: A Prospective, Non-interventional Study Investigating Oral Semaglutide Use in Adults with Type 2 Diabetes Mellitus During Ramadan.
Hassanein M, Alawadi F, AlKadhim I, Aly H, Bajawi D, Cinar T, Dhanwal D, Jabbar A, Khader S, Khudadah K, Muzaffar T, Ngome M, Nafach J, Shaghouli A; O-SEMA-FAST Investigators. Hassanein M, et al. Diabetes Ther. 2025 Apr;16(4):663-684. doi: 10.1007/s13300-025-01702-1. Epub 2025 Feb 28. Diabetes Ther. 2025. PMID: 40016571 Free PMC article.
Ameliorating effect of erythropoietin in a severe case of COVID-19: case report.
Maufak MM, Khan G, Purushothaman A, Ahamed F, Jallo MK, Rizwan M, Kumar S, Almansouri A, Almansoori TM, Ouseppachen MT. Maufak MM, et al. Among authors: jallo mk. Pan Afr Med J. 2022 Nov 9;43:129. doi: 10.11604/pamj.2022.43.129.35014. eCollection 2022. Pan Afr Med J. 2022. PMID: 36762166 Free PMC article.
Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY study.
Abusnana S, Al Awadi F, Aly H, Bashier A, Kumar Dhanwal D, Halasa T, Jallo M, Medina J, Singhal S. Abusnana S, et al. Among authors: jallo m. Diabetes Res Clin Pract. 2023 Feb;196:110183. doi: 10.1016/j.diabres.2022.110183. Epub 2022 Nov 24. Diabetes Res Clin Pract. 2023. PMID: 36436550 Free article.
13 results